Baxter International Inc.

80.85+0.0600+0.07%Vol 1.99M1Y Perf 2.80%
Sep 24th, 2021 16:00 DELAYED
BID79.77 ASK81.51
Open80.61 Previous Close80.79
Pre-Market- After-Market80.85
 - -  - -%
Target Price
94.33 
Analyst Rating
Moderate Buy 1.60
Potential %
16.67 
Finscreener Ranking
★+     44.64
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
★★     46.12
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★     52.42
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
★★+     42.97
Price Range Ratio 52W %
50.86 
Earnings Rating
Buy
Market Cap40.42B 
Earnings Date
4th Nov 2021
Alpha0.00 Standard Deviation0.06
Beta0.66 

Today's Price Range

80.5381.07

52W Range

73.1288.32

5 Year PE Ratio Range

4.9072.60

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Week
-3.30%
1 Month
9.55%
3 Months
-1.63%
6 Months
-3.07%
1 Year
2.80%
3 Years
4.38%
5 Years
70.25%
10 Years
210.18%

TickerPriceChg.Chg.%
BAX80.850.06000.07
AAPL146.920.09000.06
GOOG2 852.6616.13000.57
MSFT299.35-0.2100-0.07
XOM57.590.51000.89
WFC47.920.12000.25
JNJ164.36-0.5000-0.30
FB352.967.00002.02
GE103.800.84000.82
JPM163.041.86001.15
Financial StrengthValueIndustryS&P 500US Markets
1.50
2.40
0.42
0.78
9.70
Leverage Ratio 2.30
ProfitabilityValueIndustryS&P 500US Markets
39.10
12.50
19.60
18.10
9.26
RevenueValueIndustryS&P 500US Markets
12.20B
24.40
2.55
3.43
DividendsValueIndustryS&P 500US Markets
1.36
1.12
12.08
15.54
Payout ratio47.00
Earnings HistoryEstimateReportedSurprise %
Q02 20210.740.808.11
Q01 20210.640.7618.75
Q04 20200.760.805.26
Q03 20200.730.8313.70
Q02 20200.710.64-9.86
Q01 20200.730.8212.33
Q04 20190.880.9710.23
Q02 20190.810.899.88
Earnings Per EndEstimateRevision %Trend
9/2021 QR0.940.00-
12/2021 QR1.03-4.63Negative
12/2021 FY3.530.28Positive
12/2022 FY4.01-0.74Negative
Next Report Date4th Nov 2021
Estimated EPS Next Report0.94
Estimates Count10
EPS Growth Next 5 Years %10.00
Volume Overview
Volume1.99M
Shares Outstanding499.91M
Shares Float498.97M
Trades Count24.96K
Dollar Volume259.99M
Avg. Volume2.90M
Avg. Weekly Volume2.27M
Avg. Monthly Volume3.98M
Avg. Quarterly Volume3.33M

Baxter International Inc. (NYSE: BAX) stock closed at 80.85 per share at the end of the most recent trading day (a 0.07% change compared to the prior day closing price) with a volume of 2.01M shares and market capitalization of 40.42B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 50000 people. Baxter International Inc. CEO is Jose E. Almeida.

The one-year performance of Baxter International Inc. stock is 2.8%, while year-to-date (YTD) performance is 0.76%. BAX stock has a five-year performance of 70.25%. Its 52-week range is between 73.12 and 88.32, which gives BAX stock a 52-week price range ratio of 50.86%

Baxter International Inc. currently has a PE ratio of 38.40, a price-to-book (PB) ratio of 4.92, a price-to-sale (PS) ratio of 3.37, a price to cashflow ratio of 20.70, a PEG ratio of 2.32, a ROA of 5.57%, a ROC of 8.23% and a ROE of 13.12%. The company’s profit margin is 9.26%, its EBITDA margin is 19.60%, and its revenue ttm is $12.20 Billion , which makes it $24.40 revenue per share.

Of the last four earnings reports from Baxter International Inc., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.94 for the next earnings report. Baxter International Inc.’s next earnings report date is 04th Nov 2021.

The consensus rating of Wall Street analysts for Baxter International Inc. is Moderate Buy (1.6), with a target price of $94.33, which is +16.67% compared to the current price. The earnings rating for Baxter International Inc. stock is Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Baxter International Inc. has a dividend yield of 1.36% with a dividend per share of $1.12 and a payout ratio of 47.00%.

Baxter International Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 6.18, ATR14 : 1.43, CCI20 : 0.83, Chaikin Money Flow : 0.10, MACD : 1.11, Money Flow Index : 54.65, ROC : -2.31, RSI : 53.55, STOCH (14,3) : 13.54, STOCH RSI : 0.02, UO : 38.29, Williams %R : -86.46), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Baxter International Inc. in the last 12-months were: Albert P L Stroucken (Option Excercise at a value of $155 987), Albert P L Stroucken (Sold 4 990 shares of value $421 954 ), Andrew Frye (Sold 10 999 shares of value $932 605 ), Peter S. Hellman (Option Excercise at a value of $155 987), Peter S. Hellman (Sold 4 990 shares of value $421 954 ), Sean B.W. Martin (Option Excercise at a value of $1 005 246), Sean B.W. Martin (Sold 19 800 shares of value $1 529 748 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
10 (66.67 %)
10 (66.67 %)
7 (50.00 %)
Moderate Buy
1 (6.67 %)
1 (6.67 %)
1 (7.14 %)
Hold
4 (26.67 %)
4 (26.67 %)
6 (42.86 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.60
Moderate Buy
1.60
Moderate Buy
1.93

Baxter International Inc.

Baxter manufactures medical products across seven major reported business segments. The renal segment (32% of 2020 sales) includes peritoneal dialysis and hemodialysis products for chronically ill patients while its acute therapies segment (6%) offers kidney or other organ support tools in intensive care situations. The medication delivery segment (23% of sales) sells IV pumps, administrative sets, and solutions while its nutrition segment (8% of sales) offers parenteral nutrition therapies. The pharmaceuticals segment (18% of sales) offers injectable drugs, anesthetic gases, and compounding services. The advanced surgery segment (8% of sales) provides hemostastic products and biosurgical sealants. Contract manufacturing rounds out the remaining sales.

CEO: Jose E. Almeida

Telephone: +1 224 948-2000

Address: One Baxter Parkway, Deerfield 60015, IL, US

Number of employees: 50 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

61%39%

Bearish Bullish

56%44%

Bearish Bullish

69%31%

TipRanks News for BAX

Thu, 02 Sep 2021 13:28 GMT Baxter to Snap Up Hill-Rom for $10.5B Shares Rise Pre-Market

- TipRanks. All rights reserved.

Mon, 30 Aug 2021 11:56 GMT Will Hill-Rom Accept Baxters Offer Price of $150

- TipRanks. All rights reserved.

News

Stocktwits